Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ferraro

Showing results (351-360 of 355) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 355 results.
Bioorganic & Medicinal Chemistry Letters|October 11, 2011
Discovery of 3-hydroxy-4-cyano-isoquinolines as novel, potent, and selective inhibitors of human 11β-hydroxydehydrogenase 1 (11β-HSD1)Shung C Wu, David Yoon, Janice Chin, et al.
ERJ Open Research|June 24, 2025
Severe Paediatric Asthma Collaborative in Europe: real-world data on children on biologicsNorrice M Liu, Mariëlle W Pijnenburg, Antoine Deschildre, et al.
European Heart Journal. Cardiovascular Imaging|June 15, 2020
Non-obstructive high-risk plaques increase the risk of future culprit lesions comparable to obstructive plaques without high-risk features: the ICONIC studyRichard A Ferraro, Alexander R van Rosendael, Yao Lu, et al.
Lupus|January 27, 2025
Autoantibody clusters in childhood-onset systemic lupus erythematosus: Insights from a multicenter study with 912 patientsVitor C Trindade, Eloisa Bonfá, Ana P Sakamoto, et al.
Nature Communications|June 15, 2022
Clinical genomic profiling in the management of patients with soft tissue and bone sarcomaMrinal M Gounder, Narasimhan P Agaram, Sally E Trabucco, et al.
Pageof 36

Showing results (351-360 of 355) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 355 results.
Bioorganic & Medicinal Chemistry Letters|October 11, 2011
Discovery of 3-hydroxy-4-cyano-isoquinolines as novel, potent, and selective inhibitors of human 11β-hydroxydehydrogenase 1 (11β-HSD1)Shung C Wu, David Yoon, Janice Chin, et al.
ERJ Open Research|June 24, 2025
Severe Paediatric Asthma Collaborative in Europe: real-world data on children on biologicsNorrice M Liu, Mariëlle W Pijnenburg, Antoine Deschildre, et al.
European Heart Journal. Cardiovascular Imaging|June 15, 2020
Non-obstructive high-risk plaques increase the risk of future culprit lesions comparable to obstructive plaques without high-risk features: the ICONIC studyRichard A Ferraro, Alexander R van Rosendael, Yao Lu, et al.
Lupus|January 27, 2025
Autoantibody clusters in childhood-onset systemic lupus erythematosus: Insights from a multicenter study with 912 patientsVitor C Trindade, Eloisa Bonfá, Ana P Sakamoto, et al.
Nature Communications|June 15, 2022
Clinical genomic profiling in the management of patients with soft tissue and bone sarcomaMrinal M Gounder, Narasimhan P Agaram, Sally E Trabucco, et al.
Pageof 36